Two Sigma Investments’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-193,891
| Closed | -$25.6M | – | 3615 |
|
|
2025
Q1 | $25.6M | Buy |
193,891
+51,100
| +36% | +$6.74M | 0.05% | 396 |
|
|
2024
Q4 | $11.9M | Buy |
142,791
+119,301
| +508% | +$9.96M | 0.03% | 636 |
|
|
2024
Q3 | $1.72M | Buy |
+23,490
| New | +$1.72M | ﹤0.01% | 1710 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 3323 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 3354 |
|
|
2022
Q1 | – | Sell |
-277,359
| Closed | -$14.5M | – | 3215 |
|
|
2021
Q4 | $14.5M | Buy |
+277,359
| New | +$14.5M | 0.03% | 517 |
|
|
2021
Q2 | – | Sell |
-10,587
| Closed | -$359K | – | 2981 |
|
|
2021
Q1 | $359K | Buy |
+10,587
| New | +$359K | ﹤0.01% | 1988 |
|
|
2020
Q2 | – | Sell |
-55,926
| Closed | -$860K | – | 2454 |
|
|
2020
Q1 | $860K | Buy |
55,926
+27,246
| +95% | +$419K | 0.01% | 1017 |
|
|
2019
Q4 | $984K | Sell |
28,680
-170,340
| -86% | -$5.84M | ﹤0.01% | 1418 |
|
|
2019
Q3 | $1.49M | Sell |
199,020
-27,673
| -12% | -$207K | 0.01% | 1039 |
|
|
2019
Q2 | $2.94M | Sell |
226,693
-64,641
| -22% | -$839K | 0.01% | 933 |
|
|
2019
Q1 | $3.55M | Buy |
291,334
+98,681
| +51% | +$1.2M | 0.01% | 943 |
|
|
2018
Q4 | $2.19M | Buy |
+192,653
| New | +$2.19M | 0.01% | 1017 |
|
|
2018
Q2 | – | Sell |
-96,274
| Closed | -$2.03M | – | 2446 |
|
|
2018
Q1 | $2.03M | Sell |
96,274
-60,800
| -39% | -$1.28M | 0.01% | 1034 |
|
|
2017
Q4 | $2.27M | Buy |
+157,074
| New | +$2.27M | 0.01% | 1088 |
|
|
2015
Q2 | – | Sell |
-20,947
| Closed | -$500K | – | 2456 |
|
|
2015
Q1 | $500K | Buy |
+20,947
| New | +$500K | ﹤0.01% | 1675 |
|